Nuveen Asset Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.34M | Buy |
104,026
+317
| +0.3% | +$7.13K | ﹤0.01% | 2318 |
|
|
2024
Q3 | $2.65M | Sell |
103,709
-23,809
| -19% | -$608K | ﹤0.01% | 2283 |
|
|
2024
Q2 | $2.98M | Buy |
127,518
+44,523
| +54% | +$1.04M | ﹤0.01% | 2189 |
|
|
2024
Q1 | $1.46M | Sell |
82,995
-3,634
| -4% | -$63.9K | ﹤0.01% | 2535 |
|
|
2023
Q4 | $1.2M | Sell |
86,629
-338
| -0.4% | -$4.68K | ﹤0.01% | 2654 |
|
|
2023
Q3 | $1.19M | Buy |
86,967
+22,272
| +34% | +$304K | ﹤0.01% | 2509 |
|
|
2023
Q2 | $1.32M | Buy |
+64,695
| New | +$1.32M | ﹤0.01% | 2521 |
|
|
2021
Q2 | – | Sell |
-3,728
| Closed | -$126K | – | 3334 |
|
|
2021
Q1 | $126K | Buy |
+3,728
| New | +$126K | ﹤0.01% | 3266 |
|
|
2020
Q3 | – | Sell |
-1,989
| Closed | -$220K | – | 3255 |
|
|
2020
Q2 | $220K | Buy |
+1,989
| New | +$220K | ﹤0.01% | 3087 |
|